The impact of circulating total homocysteine levels on long-term cardiovascular mortality in patients with acute coronary syndromes

International Journal of Cardiology

Volumn 124, Issue 3, 2008, Pages 312-318

  Foussas, Stefanos G ^a   Zairis, Michael N ^a   Makrygiannis, Stamatis S ^a   Manousakis, Stavros J ^a   Patsourakos, Nikolaos G ^a   Adamopoulou, Evdokia N ^a   Beldekos, Demetrios J ^a   Melidonis, Andreas I ^a   Handanis, Stylianos M ^a   Manolis, Athanasios J ^a   Hatzisavvas, John J ^a   Argyrakis, Spyros K ^a  

^a TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

Author keywords

Acute coronary syndromes; Homocysteine; Prognosis; Risk stratification

Indexed keywords

HOMOCYSTEINE;

ACUTE CORONARY SYNDROME; ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DIABETES MELLITUS; DISEASE COURSE; DISEASE DURATION; FEMALE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SMOKING HABIT; ST SEGMENT ELEVATION;

ACUTE DISEASE; BIOLOGICAL MARKERS; CORONARY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GREECE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; SYNDROME; TIME FACTORS;

EID: 39749160406     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.02.011     Document Type: Article

References (13)

1. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., and Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337 (1997) 230-236
2. Al-Obaidi M.K., Stubbs P.J., Collinson P.O., Conroy R.M., Graham I., and Noble M.I.M. Elevated homocysteine levels are associated with increased ischemic myocardial injury in acute coronary syndromes. J Am Coll Cardiol 36 (2000) 1217-1222
3. Omland T., Samuelsson A., Hartford M., et al. Serum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes. Arch Intern Med 160 (2000) 1834-1840
4. Stubbs P.J., Al-Obaidi M.K., Conroy R.M., Collinson P.O., Graham I.M., and Noble M.I.M. Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromes. Circulation 102 (2000) 605-610
5. Matetzky S., Freimark D., Ben-Ami S., et al. Association of elevated homocysteine levels with a higher risk of recurrent coronary events and mortality in patients with acute myocardial infarction. Arch Intern Med 163 (2003) 1933-1937
6. Facila L., Nunez J.E., GVB, et al. Early determination of homocysteine levels in acute coronary syndromes, is it an independent prognostic factor?. Int J Cardiol 100 (2005) 275-279
7. Bodi V., Sanchis J., Llacer A., et al. Risk stratification in non-ST elevation acute coronary syndromes. Predictive power of troponin I, C-reactive protein, fibrinogen and homocysteine. Int J Cardiol 98 (2005) 277-283
8. Mudd S.H., Skovby F., Levy H.L., et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 37 (1985) 1-31
9. McCully K.S. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56 (1969) 111-128
10. Taylor Jr. L.M., Moneta G.L., Sexton G.J., Schuff R.A., and Porter J.M. Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease. J Vasc Surg 29 (1999) 8-19
11. Wald D.S., Wald N.J., Morris J.K., and Law M. Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. BMJ 333 (2006) 1114-1117
12. Bazzano L.A., Reynolds K., Holder K.N., and He J. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 296 (2006) 2720-2726
13. Kaul S., Zadeh A.A., and Shah P.K. Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated. J Am Coll Cardiol 48 (2006) 914-923